Options Trading News

November 27, 2012  Tue 2:14 AM CT

Biotech company Exelixis slipped yesterday, and one trader sees limited upside potential for the near term.

optionMONSTER's scanners detected the sale of more than 5,400 May 6 calls, led by a block of 4,320 that went for $0.75. Open interest in the strike was just 194 contracts at the start of the session, so this is clearly a new position.

The calls could have been sold naked in a trade that has an initial bearish bias but could profit with EXEL anywhere below $6.75 at expiration in mid-May. It is also possible that the options were traded against an existing long position in a covered call position, which would be bullish up to the strike price but would not partake in any stock gains above that level. (See our Education section)

EXEL was down 1.33 percent to close the session at $5.20 after gaining in the previous five sessions. Shares carved out their 2012 range in the last week of July and first of August, hitting $6.95 then quickly falling to lows and long-term support at $4.25.
Share this article with your friends

Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »